
Quanterix Corporation QTRX
$ 3.73
-4.49%
Annual report 2025
added 03-02-2026
Quanterix Corporation Operating Expenses 2011-2026 | QTRX
Annual Operating Expenses Quanterix Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 191 M | 136 M | 120 M | 149 M | 120 M | 79.8 M | 68.4 M | 49.5 M | 36 M | 29.5 M | 20.2 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 191 M | 20.2 M | 90.8 M |
Quarterly Operating Expenses Quanterix Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.5 M | 48.4 M | 42.8 M | - | 31.9 M | 33.2 M | 33.7 M | - | 28.7 M | 26.3 M | - | 47.5 M | 33.7 M | 32.7 M | - | 30.5 M | 27.5 M | 26.1 M | - | 18.8 M | 17.4 M | 18.5 M | - | 17.3 M | 17.4 M | 15.4 M | - | 13.3 M | 11.3 M | 10.3 M | - | 8.95 M | 11.7 M | 11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.5 M | 8.95 M | 25.7 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Sensus Healthcare
SRTS
|
22.2 M | $ 3.88 | -3.24 % | $ 63.3 M | ||
|
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Tactile Systems Technology
TCMD
|
221 M | $ 26.41 | -1.39 % | $ 604 M | ||
|
TELA Bio
TELA
|
88.1 M | $ 0.71 | -4.84 % | $ 33.3 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Tandem Diabetes Care
TNDM
|
159 M | $ 22.21 | -4.76 % | $ 1.51 B | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.63 | -0.03 % | $ 1.14 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
40.3 M | $ 24.45 | - | $ 207 M | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Viemed Healthcare
VMD
|
55.7 M | $ 9.16 | -0.65 % | $ 356 M | ||
|
Outset Medical
OM
|
113 M | $ 3.43 | -2.7 % | $ 52.2 K | ||
|
Vivos Therapeutics
VVOS
|
20.2 M | $ 1.19 | 0.02 % | $ 5.97 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.62 | 3.32 % | $ 33.7 M | ||
|
Aethlon Medical
AEMD
|
9.34 M | $ 2.23 | -1.76 % | $ 3.48 M | ||
|
PAVmed
PAVM
|
54.3 M | $ 8.91 | -0.28 % | $ 64.4 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
InspireMD
NSPR
|
52.3 M | $ 1.7 | -1.73 % | $ 109 M | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.32 | -0.79 % | $ 1.53 B | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.45 | 1.24 % | $ 6.8 M | ||
|
Penumbra
PEN
|
753 M | $ 335.61 | -0.24 % | $ 13.1 B | ||
|
MiMedx Group
MDXG
|
277 M | $ 3.87 | -1.78 % | $ 572 M | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
26.8 M | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
41.3 M | $ 0.66 | -2.85 % | $ 27.6 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 49.09 | -2.7 % | $ 1.44 B | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.21 | -2.82 % | $ 49.2 M | ||
|
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
777 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
396 M | - | - | $ 217 M |